EXCLUSIVE: A former senior DEA official who testified before Congress on the government's efforts to stop the opioid epidemic is now working for Oxycontin maker Purdue Pharma
, is one of the opioid companies being sued by more than 1600 cities and counties for"grossly" misrepresenting"the risks of long-term use of those drugs for persons with chronic pain," according to court documents. The lawsuits have been consolidated into one case in federal court in Cleveland, Ohio. Purdue vigorously denies allegations that they deceptively marketed OxyContin.
Purdue has reportedly made more than $35 billion from the sale of OxyContin, a figure the company has not denied. Ashley said that 3.4 million Americans reported misusing prescription painkillers in 2016, and the scope of the opioid problem"underscores the need for a robust regulatory program that seeks to stop diversion of CPDs [controlled prescription drugs]."The avalanche of legal cases against opioid manufacturers and distributors has been likened to the lawsuits that were faced by the tobacco industry, which ultimately settled in 1998 for $206 billion.
इंडिया ताज़ा खबर, इंडिया मुख्य बातें
Similar News:आप इससे मिलती-जुलती खबरें भी पढ़ सकते हैं जिन्हें हमने अन्य समाचार स्रोतों से एकत्र किया है।
Bankruptcy is ‘an option’ for OxyContin maker Purdue Pharma, CEO saysPurdue Pharma is facing a cascade of lawsuits alleging that the drugmaker played a key role in driving the nation’s opioid crisis.
और पढो »
Purdue Pharma CEO says bankruptcy is ‘an option’ as company faces opioid lawsuitsCraig Landau told The Washington Post that Purdue is developing a powerful anti-overdose drug in a pro-bono effort to combat the effects of the opioid crisis.
और पढो »
Purdue Pharma CEO says company considering bankruptcy: Washington PostPurdue Pharma's Chief Executive Officer Craig Landau said the company is co...
और पढो »
London Gallery Will Forgo Donation From Purdue Pharma’s Sackler FamilyBritain’s National Portrait Gallery won’t proceed with a $1.3 million pledge from a charitable organization overseen by some members of the Sackler family, owners of OxyContin maker Purdue Pharma.
और पढो »
Purdue University bans Netflix, other streaming services for students in academic buildingsAdministrators hope the ban will alleviate issues of internet access and speed on campus, freeing up more bandwidth for academic resources.
और पढो »
Gillibrand pledges to go after drug companies over opioid crisisSen. Kirsten Gillibrand said that drug manufacturers should be prosecuted for their role in the opioid crisis, and that if she's elected president, she'll attempt to hold companies like Purdue Pharma responsible.
और पढो »
FDA medical adviser: 'Congress is owned by pharma'Despite many politicians, particularly declared presidential candidates, beginning to speak out against big pharma, an FDA medical adviser does not think that anything will come out of it “because Congress is owned by pharma.”
और पढो »
OxyContin's maker is accused of fueling the opioid epidemic. Its new overdose antidote was just fast-tracked by the FDAThe US Food and Drug Administration granted Purdue Pharma's experimental opioid overdose drug fast-track designation. According to Purdue, its drug, nalmefene hydrochloride injection, has a longer effect than naloxone, another opioid antagonist that is approved to reverse overdoses.
और पढो »
Dispensed: New Theranos footage, an e-cig crackdown, and the pharmacy powering DTC companies like HimsWelcome to Dispensed, Business Insider's weekly newsletter giving you a dose of pharma, biotech, and healthcare news.
और पढो »